Previous Article | Next Article ![]()
Journal of Virology, October 1998, p. 8349-8353, Vol. 72, No. 10
Department of Molecular Biology, Beckman
Research Institute of the City of Hope, Duarte, California
910101;
Biological Sciences Department,
California State Polytechnic University, Pomona, California
917682; and
Institut de Genetique
Moleculaire de Montpellier
Received 13 March 1998/Accepted 17 June 1998
We have used a strategy for colocalization of Psi ( All retroviruses require packaging
of two genomic RNAs for infectivity. The viral sequences that direct
correct encapsidation, known as the psi ( In Moloney murine leukemia virus (MoMuLV), in vitro analyses have
demonstrated that dimerization can occur in the absence of virally
encoded proteins under appropriate salt and temperature conditions
(11, 19, 22). Kinetic studies suggest that dimerization is a
multistep process involving a series of intermolecular associations between structured elements in the In order to investigate the in vivo mechanics of the dimerization
reaction, we have devised a ribozyme strategy which takes advantage of
the demonstrated virion colocalization of p
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Monitoring Retroviral RNA Dimerization In Vivo via
Hammerhead Ribozyme Cleavage
CNRS, Montpellier,
France3
![]()
ABSTRACT
Top
Abstract
Text
References
)-tethered
ribozymes and targets to demonstrate that
sequences are capable of
specific interaction in the cytoplasm of both packaging and nonpackaging cells. These results indicate that current in vitro dimerization models may have in vivo counterparts. The methodology used
may be applied to further genetic analyses on
domain interactions in vivo.
![]()
TEXT
Top
Abstract
Text
References
) element, are located in
the 5' end of the genomic RNA beginning downstream from the primer
binding site and extending into the 5' gag coding region of
the viral RNA (1, 4, 16, 23). Extracted retroviral genomic
RNAs of various origins have been shown by electron microscopy to be
linked close to their 5' ends in a parallel orientation, forming dimers
(5, 15, 18); the dimerized region maps within the
element. Sequences within the
element forming a series of conserved
stem-loops have been shown to be capable of dimer formation under
appropriate in vitro conditions. Deletion or modification of these
sequences in the context of the virus have effects on encapsidation or
infectivity, depending on the exact mutation. Consequently,
dimerization is thought to be required in vivo both in selective
encapsidation of unspliced viral genomic-length RNAs and in the early
steps of replication occurring immediately postinfection.
domains. The addition of the
MoMuLV nucleocapsid protein 10 (NCp10), derived from the gag precursor in vivo, stimulates the in vitro formation of dimers (7). Thus far, stimulation of dimer formation by NCp10 is
confined to subgenomic RNAs, and no in vitro dimerization of
full-length viral genomic RNAs has yet been observed. Based upon the in
vitro observations, it is believed that formation of stable dimers of genomic viral RNAs in vivo requires virally encoded gag
protein(s).
-tethered ribozyme and
targets (21). We wished to determine whether or not the
element would allow ribozyme-target colocalization in the cytoplasm of
the infected cell independent of packaging, and if so, whether viral
proteins were required for this process. The experimental design
therefore is dependent upon the formation of heterodimers between the
ribozyme-encoding RNAs and the target RNAs. Many factors could bias the
formation of homodimers over heterodimers, including the nature of the
element, the levels of transcripts, and the coexpression of
transcripts. To address this problem, we have designed target and
ribozyme retroviral vectors derived from the MoMuLV vector pLNL-6
(1) (Fig. 1A) which utilize
antibiotic resistance markers to monitor transfection efficiency. All
of the constructs are deficient in the coding regions for
pol, env, and the major part of the
gag gene but retain the sequences known to be required for
dimerization and packaging (the
region) (Fig. 1A). Each contains
the MoMuLV long terminal repeats (LTRs) which direct transcription of
only a single RNA initiating in the 5' LTR and terminating in the 3'
LTR (Fig. 1A). For clarity, pLNL-6 is referred to as p
neo. An
additional pair of constructs derived from pLNL-6 have the
neo gene replaced by the hygro gene, maintain the
MoMuLV
sequences, and have either a functional anti-neo
ribozyme (p
hygRbz) or a ribozyme crippled by a double point mutation
(p
hyg*Rbz) (Fig. 1B and C and Fig. 2)
appended immediately after the hygro coding region.

View larger version (36K):
[in a new window]
FIG. 1.
Linear maps of retroviral vectors used in this study.
The MoMuLV-based retroviral vector, pLNL-6 (p
neo) was kindly
provided by A. Dusty Miller of the Fred Hutchinson Cancer Research
Center, Seattle, Wash. (1), and served as the basic vector
for all of the constructs in this study. Target plasmids p
neo (A)
and p
neo (D) contain the neomycin phosphotransferase
(neo) gene, allowing selection of transfected cells with
G418. Retroviral vectors expressing a ribozyme (p
hygRbz) (B) or a
mutant ribozyme (p
hyg*Rbz) (C) were derived from pLNL-6 by
replacement of the neo gene with hygromycin
phosphotransferase (hygro)-Rbz or hygro-*Rbz
constructs. Specifically, a 1.1-kb BamHI fragment containing
the hygro gene was subcloned upstream of either a functional
or a mutant ribozyme gene in pBluescript. The hygro-ribozyme
segments were inserted into the BclI and
HindIII sites of pLNL-6 (B and C). This functionally
destroyed both the BclI and BamHI sites in the
LTR-hygromycin-LTR (LHL) vectors.
The sequence of the anti-neo hammerhead ribozyme insert is
CTA GAG GAT CCA CCA TGG TTG ATC AGC ATG CGG CGA CTG* ATG AGT CCG TGA
GGA CG*A AAC CGT AAA GCA CGA GGA AGC GGT CAG CCC AT. In the mutant
ribozyme construct, two point mutations were created in the catalytic
domain of the hammerhead ribozyme by substituting thymidines for
guanosines at the indicated (*) positions.

neo (D) was constructed by removing a
SpeI-BclI fragment (nucleotides 870 to 1625;
GenBank accession no. M63653), which contains most of the
sequence,
from pLNL-6.

View larger version (16K):
[in a new window]
FIG. 2.
Pairing of the anti-neo ribozyme with its
target in LNL-6. The ribozyme cleavage site in the neo
transcript is between nucleotides 2391 and 2392 in the pLNL-6 sequence
and is approximately 1,800 nucleotides downstream of the start point of
transcription. Since the ribozyme cloning site in the p
hygRbz vector
was constrained to a site just downstream of the hygro
coding region, the neo target site was chosen to position it
at the same relative distance from the messenger cap site as the
ribozyme, to enhance the probability of the ribozyme pairing arms
interacting with the target sequence in the dimerized RNAs. The
ribozyme has asymmetric base pairing, with 6 bp in stem I and 32 bp in
stem III. The long stem III facilitates the ribozyme and target
association, whereas once cleavage has taken place, the short stem I
facilitates rapid product dissociation and possibly hastens the
ultimate degradation of the cleaved RNA (16). To control for
ribozyme versus antisense activity, we generated a mutant, inactive
version of the anti-neo ribozyme and inserted it in place of
the functional ribozyme in p
hyg*Rbz (Fig. 1C).
Initially, we wished to ascertain whether or not the ribozyme targeting
would give a readily discernible phenotype. The ribozyme and target
retroviral vectors were transfected and/or cotransfected into the
murine retroviral PA317 (ATCC) packaging cell line to take advantage of
constitutively produced viral proteins that enhance the dimerization of
the viral RNAs in vitro (8, 9). The PA317 cell line is a
derivative of NIH 3T3 mouse embryo fibroblasts carrying truncated mouse
retroviral DNA (lacking the
element, the 3' LTR, and part of the 5'
LTR) and the herpes simplex thymidine kinase (TK) gene (both in
pBR322). To ensure maintenance of the packaging phenotype, PA317 cells
were reselected with HAT (hypoxanthine, aminopterin, and thymidine).
The PA317 cells were maintained in Dulbecco-modified minimum essential
medium (DMEM)-high glucose (Irvine Scientific) supplemented with 10%
fetal bovine serum. PA317 cells (105 cells) were plated
into 60-mm tissue culture dishes (Falcon) 24 h prior to
transfection, and the medium was changed 5 to 6 h before
transfection. Cells were transfected according to the manufacturer's
protocol for Cell Phect (Pharmacia Biochem) by using the following
plasmid combinations: (i) p
neo alone, (ii) p
neo plus p
hygRbz,
and (iii) p
neo plus p
hyg*Rbz (2:1 ratio of Rbz to target vectors;
9 µg of total plasmid DNA). Cells were subjected to a glycerol shock
after 16 h. Selection was begun 24 h later in medium
containing 500 µg of G418 (Mediatech)/ml plus 50 µg of
hygromycin/ml after trypsinization, dilution, and replating. Selection
was continued until well-isolated colonies appeared (3 to 5 weeks). The
results from transfections carried out in triplicate are presented in
Fig. 3. The number of stably transfected
G418-resistant colonies was reduced approximately 100-fold in the
presence of the functional ribozyme and 2-fold in the presence of the
crippled ribozyme relative to colonies arising after transfection with
p
neo alone. These results are consistent with a specific ribozyme
effect.
|
In order to verify that the reduction in G418-resistant clones was a
consequence of ribozyme-mediated destruction of the neo transcript and was not due to nonspecific toxicities, we carried out an
experiment using the same constructs but scoring separately for G418
and hygromycin resistance (Fig. 4). To
assay for colocalization, one ribozyme and one target construct were
cotransfected into target cells in all four combinations as above (for

construct, see below). After transfection, the cells were
divided equally, and one half was subjected to G418 and the other half
to hygromycin B (50 µg/ml; Sigma) selection. Since only the ribozyme
and mutant ribozyme constructs carry the hygro gene, the
number of hygromycin-resistant colonies serves to normalize the
transfection efficiencies. In all cases, the numbers of
hygromycin-resistant clones were similar, regardless of the combination
of vectors used in the transfections (Fig. 4). The number of
G418-resistant colonies monitored neo gene expression from
the target vectors. As observed in the first set of experiments, the
functional ribozyme severely inhibited the formation of G418-resistant
colonies, whereas the mutant ribozyme had little effect.
Consequently, nonspecific effects of dimerization, such as interference
with translation, cannot be solely responsible for the reduction in
G418-resistant colony formation; otherwise, significantly fewer
hygromycin-resistant colonies would arise in the p
neo-p
hygRbz
than in the p
neo-p
hygRbz combination. Likewise, the modest
reduction in G418-resistant colonies in the mutant ribozyme
transfections supports this view.
|
In order to examine the role of the
region in ribozyme targeting
and efficacy, a 752-base segment of pLNL-6 encompassing sequences known
to be required for dimerization and packaging of the viral RNAs was
deleted by cleaving the unique SpeI and BclI
sites in the vector, filling in the ends, and blunt-end ligating them
together. We refer to the construct with
deleted as p
neo (Fig. 1D).
To assay for colocalization, one ribozyme and one target construct were
cotransfected into PA317 cells in all four combinations, along with
single transfection controls. The assay is based on the premise
that if in vivo
-dependent colocalization occurs intracellularly,
fewer G418-resistant colonies should form when the ribozyme
vector is cotransfected with the
-containing target than when it is
cotransfected with the 
target, due to enhancement of ribozyme
activity via
-dependent colocalization with the target. The numbers
of G418- and G418- and hygromycin-resistant colonies were scored (Fig.
5). Once again there was a marked
reduction in the number of G418-resistant clones obtained when the
p
neo target was cotransfected with p
hygRbz, compared to
p
hyg*Rbz. Most importantly, the dramatic reduction in G418-resistant
colonies was lost following removal of the
element from the target
vector (p
neo-p
hygRbz). Removal of the
sequence from the
target did not affect the number of G418-resistant stable clones
obtained, showing that the presence or absence of the
sequence
itself does not affect neo gene expression (Fig. 5).
Consequently, colony formation cannot be due to viral spread or
superinfection. Moreover, the variation in the number of
hygromycin-resistant colonies generated by p
hyg*RBZ and
p
hygRBZ is always less than twofold, regardless of the cotransfected
target. The same is true whether hygromycin selection alone (Fig.
4) or hygromycin and G418 selection is used (Fig. 5; compare
p
neo-p
hyg*Rbz, p
neo-p
hyg*Rbz, and
p
neo-p
hygRbz). We conclude from these results that
-directed association of retroviral RNAs occurs intracellularly
prior to viral encapsidation.
|
Dimerization of retroviral RNA can occur independently of nucleocapsid
protein in vitro (14). In order to evaluate the role of
nucleocapsid proteins in dimerization as measured by ribozyme-mediated inactivation of the neo transcript in vivo, we repeated the
transfection assay using the human 293 nonpackaging cell line. The
protocol was identical to that used with PA317 cells, except that cells were glycerol shocked 6 h posttransfection. The results obtained from these transfection experiments suggest that intracellular dimerization and consequent ribozyme-target colocalization can occur in
the absence of the viral nucleocapsid proteins, albeit less efficiently
than in their presence (Fig. 6A). The
data from the 293 cell transfections confirm that the presence of the
element is essential for this process (Fig. 6B).
|
Sullenger and Cech (21) demonstrated
-dependent
colocalization of a retroviral vector RNA expressing a ribozyme with a
-tethered lacZ target. Their results demonstrated that
copackaging of these two RNAs into virions resulted in reduction of the
titer of lacZ transduction by 90%, clearly a function of
ribozyme destruction of the target RNA. They were unable to detect
ribozyme-mediated reduction of LacZ activity in the cell cytoplasm and
saw the ribozyme effect only after virion packaging and transduction of
target cells. A difference between their experimental approach and ours was that their target RNA was expressed from a stably transformed cell
line, and the ribozyme-encoding viral vector was transduced into these
cells. In contrast, we cotransfected the two DNAs into the same cells,
thereby allowing coordinated expression of the RNAs and increasing the
likelihood that the
elements from the two vectors could interact.
In addition, we have shown that >90% of the transcripts generated by
pLNL6 (p
neo) and derivatives containing other ribozymes are
unspliced and therefore contain the entire
domain, which
optimizes chances for colocalization in these experiments
(24).
The
elements of retroviruses are required for the production of
functional virions by virtue of their intrinsic ability to dimerize. A
combination of chemical probing data, sequence analysis of related
viruses, and computer folding was used to predict a complex secondary
structure for the MoMuLV domain (2, 22) containing 10 stem-loop structures. Based on the predicted structure and further in
vitro data, Girard et al. (11, 12) proposed a model for a
sequential series of intermolecular interactions between
domains
leading to dimerization. First, transient intermolecular pairing
between complementary sequences in loops 1 and 4 and loops 2 and 5 promote weak association of genomic RNA monomers. This association is
thought to bring the critical C278-to-G303
stem-loop into apposition and induce a conformational rearrangement where the stem-loop opens, facilitating loop-loop annealing by the
internal autocomplementary sequence
5'-U288AGCUA293-3' and formation of a more
stable dimer. Kinetic analyses of
-mediated dimer formation in the
presence of NCp10 shows that the protein does not modify the steps in
dimerization but rather lowers the energy barrier to the annealing step
by destabilizing the critical C278-to-G303
stem-loop (11, 12).
In the present study, we observe
-mediated association (as measured
by
-dependent ribozyme activity) in both packaging and nonpackaging
cell lines. Since gag-derived proteins, including NCp10, are
absent in the nonpackaging line, the observed ribozyme activity
reflects gag-independent
interactions. Therefore, our results are consistent with the existence in vivo of the weak interactions in the first step of dimerization proposed in the above
model. One possibility is that this interaction occurs within the
nucleus, perhaps transiently, facilitating ribozyme cleavage prior to
nucleus-to-cytoplasm transport. A second possibility (the two are not
mutually exclusive) is that the ribozyme-target association occurs in
the cytoplasm in a manner that allows both translation of resistance
proteins and ribozyme cleavage. Certainly, the
association itself
does not appear to be inhibitory to translation (since hygromycin
resistance is unaffected by any of the constructs and the mutant
ribozyme has only a weak inhibitory effect on G418 resistance). This
would be consistent with the existence of a weak interaction, as it is
difficult to imagine that translation could proceed effectively through
the fully stabilized dimer structure. It is possible that a changeover
from translation to packaging of the viral genomic sequences during the
latter stages of the viral replication cycle might reflect a transition
from the formation of loose dimers to tight (gag-dependent)
dimers.
The results presented here demonstrate that
-mediated
ribozyme-target heterodimers can be formed quite efficiently and that such heterodimerization can occur independently of packaging. Thus, our
-ribozyme system could serve as a model for examining critical
components and steps of the dimerization and subsequent packaging
reactions in vivo. Since all known retroviruses have dimerization
domains, these analyses could be carried out on other retroviruses,
including the lentiviruses, and could conceivably be used for the
development of inhibitory trans-acting sequences which
compete with normal dimerization. These studies may also prove to be a
useful paradigm for studying other intracellular RNA dimerization, and
consequently RNA-RNA annealing reactions (3, 10, 17, 20).
| |
ACKNOWLEDGMENTS |
|---|
We thank R. Reinke, R. Thomas, L. Ieshu, and W. J. Fitzgerald for technical assistance and S. Westaway for critical reading of the manuscript.
This work was supported by grants AI29329, AI38592, and GM53933 from the National Institutes of Health.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Molecular Biology, Beckman Research Institute of the City of Hope, 1450 E. Duarte Rd., Duarte, CA 91010-3011. Phone: (626) 301-8360. Fax: (626) 301-8271. E-mail: jrossi{at}.coh.org.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Adam, M. A., and A. D. Miller. 1988. Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions. J. Virol. 62:471-480. |
| 2. | Alford, R. L., S. Honda, C. B. Laurence, and J. W. Belmont. 1991. RNA secondary structure analysis of the packaging signal for Moloney murine leukemia virus. Virology 183:611-619[Medline]. |
| 3. | Awang, G., and D. Sen. 1993. Mode of dimerization of HIV-1 genomic RNA. Biochemistry 32:11453-11457[Medline]. |
| 4. |
Bender, M. A.,
T. D. Palmer,
R. E. Gelinas, and A. D. Miller.
1987.
Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region.
J. Virol.
61:1639-1646 |
| 5. | Bender, W., and N. Davidson. 1976. Mapping of poly(A) sequences in the electron microscope reveals unusual structure of type C oncornavirus RNA molecules. Cell 7:595-607[Medline]. |
| 6. | Bertrand, E., and J. J. Rossi. 1996. Anti-HIV hammerhead ribozymes: targeting strategies and optimization of intracellular function, p. 301-313. In F. Eckstein, and D. Lilley (ed.), Nucleic acids and molecular biology. Springer-Verlag, New York, N.Y. |
| 7. | Bonnet-Mathonière, B., P.-M. Girard, D. Muriaux, and J. Paoletti. 1996. Nucleocapsid protein 10 activates dimerization of the RNA of Moloney murine leukemia virus in vitro. Eur. J. Biochem. 238:129-135[Medline]. |
| 8. |
de Rocquigny, H.,
C. Gabus,
A. Vincent,
M.-C. Fournié-Zaluski,
B. Roques, and J.-L. Darlix.
1992.
Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers.
Proc. Natl. Acad. Sci. USA
89:6472-6476 |
| 9. |
Feng, Y.-X.,
T. D. Copeland,
L. E. Henderson,
R. J. Gorelick,
W. J. Bosche,
J. G. Levin, and A. Rein.
1996.
HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro.
Proc. Natl. Acad. Sci. USA
93:7577-7581 |
| 10. |
Fu, W., and A. Rein.
1993.
Maturation of dimeric viral RNA of Moloney murine leukemia virus.
J. Virol.
67:5443-5449 |
| 11. | Girard, P.-M., B. Bonnet-Mathonière, D. Muriaux, and J. Paoletti. 1995. Auto complementary sequence in the 5' leader region is responsible for dimerization of MoMuLV genomic DNA. Biochemistry 34:9785-9794[Medline]. |
| 12. | Girard, P.-M., H. de Rocquigny, B.-P. Roques, and J. Paoletti. 1996. A model of PSI dimerization: destabilization of the C278-G303 stem-loop by the nucleocapsid protein (NCp10) of MoMuLV. Biochemistry 35:8705-8714[Medline]. |
| 13. | Gritz, L., and J. Davies. 1983. Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae. Gene 25:179-188[Medline]. |
| 14. |
Housset, V.,
H. de Rocquigny,
B. P. Roques, and J.-L. Darlix.
1993.
Basic amino acids flanking the zinc finger of Moloney murine leukemia virus nucleocapsid protein NCp10 are critical for virus infectivity.
J. Virol.
67:2537-2545 |
| 15. | Kung, H. J., S. Hu, W. Bender, J. M. Bailey, N. Davidson, M. O. Nicolson, and R. M. McAllister. 1976. RD-114, baboon, and wooly monkey viral RNAs compared in size and structure. Cell 7:609-620[Medline]. |
| 16. | Mann, R., R. C. Mulligan, and D. Baltimore. 1983. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33:153-159[Medline]. |
| 17. | McBride, M. S., and A. T. Panganiban. 1996. The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. J. Virol. 70:2963-2973[Abstract]. |
| 18. |
Murti, K. G.,
M. Bondurant, and A. Tereba.
1981.
Secondary structural features in the 70S RNAs of Moloney murine leukemia and Rous sarcoma viruses as observed by electron microscopy.
J. Virol.
37:411-419 |
| 19. |
Roy, C.,
N. Tounekti,
M. Mougel,
J.-L. Darlix,
C. Paoletti,
C. Ehresmann,
B. Ehresmann, and J. Paoletti.
1990.
An analytical study of the dimerization of in vitro generated RNA of Moloney murine leukemia virus (MoMuLV).
Nucleic Acids Res.
18:7287-7292 |
| 20. | Sakuragi, J.-I., and A. T. Panganiban. 1997. Human immunodeficiency virus type 1 RNA outside the primary encapsidation and dimer linkage region affects RNA dimer stability in vivo. J. Virol. 71:3250-3254[Abstract]. |
| 21. |
Sullenger, B. A., and T. R. Cech.
1993.
Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA.
Science
262:1566-1569 |
| 22. |
Tounekti, N.,
M. Mougel,
C. Roy,
R. Marquet,
J.-L. Darlix,
J.-L. Paoletti,
B. Ehresmann, and C. Ehresmann.
1992.
Effect of dimerization on the conformation of the encapsidation domain of Moloney murine leukemia virus RNA.
J. Mol. Biol.
223:205-220[Medline].
|
| 23. | Varmus, H., and R. Swanstorm. 1982. Replication of retroviruses, p. 369-512. In R. Weiss, N. Teich, H. Varmus, and J. Coffin (ed.), RNA tumor viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 24. | Zhou, C., I. C. Bahner, G. P. Larson, J. A. Zaia, J. J. Rossi, and D. B. Kohn. 1994. Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. Gene 149:33-39[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»